Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 22.25 M23.28 M24.3 M23.68 M 93.51 M Research & development ———— — Operating income 94.19 M114.4 M120.04 M134.25 M 462.89 M Non-Operating Income, Total -2.18 M-3.23 M6.78 M-865 K 499 K Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses -2.06 M-3.21 M6.99 M-865 K 850 K Unusual income/expense -122 K-17 K-212 K57.38 M 57.03 M Pretax income 101.43 M119.72 M134.24 M199.72 M 555.11 M Equity in earnings ———— — Taxes 5.5 M7.1 M9.03 M60.46 M 82.09 M Non-controlling/minority interest ———— — After tax other income/expense -66 K-110 K-109 K-124 K -409 K Net income before discontinued operations 95.93 M112.63 M125.21 M139.26 M 473.03 M Discontinued operations ———— — Net income 95.93 M112.63 M125.21 M139.26 M 473.03 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 95.93 M112.63 M125.21 M-9.91 M 323.85 M Basic earnings per share (Basic EPS) 2.683.143.493.9 13.21 Diluted earnings per share (Diluted EPS) 2.663.113.45-0.27 13.05 Average basic shares outstanding 35.77 M35.83 M35.83 M35.81 M — Diluted shares outstanding 36.1 M36.25 M36.3 M36.25 M — EBITDA 78.31 M97.3 M101.34 M— — EBIT 79.33 M98.3 M102.25 M— — Cost of revenue 861.69 M995.21 M1.07 B1.16 B 4.08 B Other cost of goods sold 2.29 M852 K-753 K292 K 2.68 M Depreciation & amortization (cash flow) -1.02 M-995 K-905 K900 K -2.02 M